Preventing Heart Disease in the Digital Age: How ECG Monitoring and Telemedicine are Changing the Landscape

By Nesli Williams, Director of Marketing at Cardiac Insight

 
A cardiologist examining medical documents

According to the latest numbers from the World Health Organization, cardiovascular diseases (CVD) are the leading cause of death globally. Today’s advances in sensor technology, communication, data processing, analytics algorithms, could usher in a new era of smart, proactive solutions for assessment, control and prevention of CVDs.1 With the exponential rise in digital health utilization since the late 20th century, cardiology providers now have more options than ever to leverage digital health solutions to improve cardiac outcomes.

Read More »

The Rise of Personalized Medicine in Cardiac Care: How Long-Term Monitoring Can Improve Outcomes

By Efia Barnes, Clinical Services and Education

 
A cardiologist meeting with a patient

Among the many challenges facing today’s healthcare system, early detection in real time ranks near the top of the list.1 The standard snapshot approach with measurements at a single or few points in time, often fails to capture the full dynamic picture of disease progression in each individual, causing healthcare providers to reactively — not proactively — treat patients. Personalized medicine opens the door to tailored interventions that more effectively target, prevent, and treat potentially life-altering cardiac conditions.

Read More »

The Role of Technology in Cardiac Care

By Nesli Williams, Sr. Manager of Marketing Communications, Ambulatory Cardiology & Digital Health at Cardiac Insight

 

The Cardea Solo ECG System

As the healthcare industry continues to innovate patient care, cardiology providers are paying close attention to how these new technologies can improve their practices. Cardiac care may benefit the most from recent developments, given the growing prevalence of heart conditions and the associated diagnostic challenges. Among the several emerging technologies in the cardiac space, four of the most impactful innovations include:

Read More »

Preventive Cardiology and Wearable ECG Devices

By Nesli Williams, Sr. Manager of Marketing Communications, Ambulatory Cardiology & Digital Health at Cardiac Insight

 

Historically, atrial fibrillation (AFib) was most commonly diagnosed in older adults, with 70% of cases found in patients between ages 65 and 85.1 However, many of the associated lifestyle risk factors — such as obesity and hypertension — are increasing in prevalence. As a result, this once age-related disease now targets all populations. The largest nationwide population-based cohort study to date evaluated Korean AFib patients across all age groups, and found that AFib increased the risk of all-cause death nearly four times, with the highest standardized mortality ratio found in younger (< 20 years old) patients.2

These alarming statistics demonstrate the urgent need for a new approach to AFib treatment, as simply managing the disease is no longer enough to improve outcomes and reduce mortality rates.

Read More »

Solutions to Unmet Clinical Needs

By Abby Massey, Director, Clinical Services & Education

Cardiac Insight

 
A cardiologist meeting with a patient

While ambulatory ECG monitoring has certainly improved since the introduction of the short-term Holter monitor, even recent innovations in prescription wearable technology face significant challenges that limit clinical performance and diagnostic accuracy, including:
Read More »

Update: Cardiac Complications Post-COVID and the need for ECG Monitoring

Commentary by Robert Hauser, MD

Chair, Cardiac Insight Scientific Advisory Board

 

Dr. Robert Hauser

Dr. Robert Hauser

SARS-CoV-2 most notably causes respiratory symptoms, but the virus can infect almost any organ in the body.1 With almost four years of data on the COVID-19 pandemic, physicians and researchers alike are closely monitoring how the disease progresses from short-term infections to long-term complications.

Read More »

Screening for sudden cardiac arrest risks in young athletes

By Abby Massey

Director, Clinical Services & Education at Cardiac Insight

 

Abby Massey

Abby Massey

Protecting youth by identifying the heart conditions putting them at risk

 
Sudden cardiac arrest (SCA) can occur without warning or prior indication of heart disease. The disrupted blood flow interferes with oxygen delivery to vital organs, which can quickly become fatal if the heart is not resuscitated.

SCA is the leading medical cause of death on school campuses and is especially common among student athletes.1 The CDC estimates that SCA is responsible for 2,000 deaths every year in patients under 25 years old.2

Read More »

Atrial Fibrillation: Early rhythm control comes of age

Commentary by Robert Hauser, MD

Chair, Cardiac Insight Scientific Advisory Board

 

Dr. Robert Hauser

Dr. Robert Hauser

Clinical atrial fibrillation (AF) is associated with increased rates of stroke, heart failure, mortality, hospitalization, and cognitive decline. For years oral anticoagulation and rate control have been the mainstays of treatment. But now, with the advent of new techniques, AF ablation has become a safe and effective method for maintaining sinus rhythm. The challenge for practitioners is to identify AF in their patients as soon as possible so that the proper management strategy can be implemented early in the course of the disease.

Read More »

Accelerating Results in Cardiac Arrhythmia Diagnostics

Ann Demaree, RN

Vice President of Marketing & Business Development

 

A patient wearing Cardea SOLO

A patient wearing Cardea SOLO

When doctors outsource for test results, the “wait” begins for the provider and staff, as well as for the anxious patient. In many cases, the delay to get the results back is measured in days, but some types of outsourced tests can often take weeks. One of the most notable testing delays in the industry occurs in outsourced electrocardiogram (ECG) testing. Ambulatory ECG testing is prescribed in order to rule out abnormal cardiac rhythms in symptomatic or high-risk patients. As longer duration, multi-day prescription ambulatory ECG test recordings are being increasingly prescribed versus traditional, cabled 1- or 2-day Holter ECG recorders, this shift has led to increased IDTF technical analysis outsourcing to handle large amounts of ECG data.

Read More »